| Size | 100 µg |
| Estimated Lead Time | 1-2 business days |
| Species | SARS-CoV-2 |
| Accession Number | QHD43423 |
| Protein Name / Synonyms | Nucleocapsid Protein, N Protein |
| Expressed Region | Met1-Ala419 |
| Expression System | HEK293 cells |
| Tag | C-terminal his-tag |
| Purity | >90 % |
| Purity Determined By | SDS-PAGE under reducing conditions and visualized by Coomassie blue staining |
| Molecular Weight (kDa) | Recombinant protein product has a calculated molecular mass of 47 kDa. Due to the abundant glycosylation, it migrates as approximately 55 kDa major protein band in SDS-PAGE under DTT, beta-mercaptoethanol reducing conditions. The minor small protein bands (25-30 kDa) likely the cleaved products. See deglycosylation analysis image below. |
| Format | Liquid |
| Formulation | Supplied as a 0.2 µm filtered solution in PBS (pH 7.4) |
| Concentration (lot specific) | Lot specific (see the label on the vial), determined by BCA protein assay |
| Research Area | Infectious Disease, COVID-19 |
| Shipping Type | Blue ice |
| Storage | -20°C |
SARS-CoV-2 relies on its nucleocapsid (N) protein to package and protect its RNA genome within the viral particle. Beyond its role in viral replication and assembly, the N protein also interacts with host immune signaling pathways, potentially modulating immune responses and disease severity. Due to its high immunogenicity, it is widely used as a diagnostic target for detecting SARS-CoV-2 infection.
Reference: https://journals.plos.org/plospathogens/article?id=10.1371/journal.ppat.1012886

Your cart is empty.
Recombinant SARS-CoV-2 Nucleocapsid Protein
It works well for fluorescent labelling and confocal microscopy.
Review by Anonymous, from University of California, Davis, on Mar 19, 2021
Recombinant SARS-CoV-2 Nucleocapsid Protein